Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 30 June 2014, Pascal Soriot, a Director of the Company, notified us that, on 30 June 2014, he purchased...
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 26 June 2014, Marc Dunoyer, a Director of the Company, notified us that, on 25 June 2014, he purchased...
-
AstraZeneca today announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 11 to 2 that current evidence from clinical studies does not support an...
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 16 June 2014, we were notified that, on 11 June 2014, Dr Briggs Morrison, a person discharging managerial...
-
+-------------+-++++--------------+ | | | +-------------+-++++--------------+ | | | +-------------+-++++--------------+ | ...
-
Transaction by Person Discharging Managerial Responsibilities Disclosure Rule DTR 3.1.4 On 16 June 2014, the interest of Mr Marc Dunoyer, a person discharging managerial responsibilities, in the...
-
US FDA ADVISORY COMMITTEE RECOMMENDS NO CARDIOVASCULAR OUTCOMES TRIAL FOR PERIPHERALLY-ACTING MU-OPIOID RECEPTOR ANTAGONIST (PAMORA) CLASS INCLUDING MOVANTIK AstraZeneca announced today that the...
-
ASTRAZENECA IN-LICENSES SYNAIRGEN'S SNG001 AS A NOVEL IMMUNO-MODULATORY THERAPY FOR VIRAL-INDUCED EXACERBATION IN ASTHMA Phase IIa clinical study to commence in patients with severe...
-
ASTRAZENECA TO PRESENT NEW DATA FROM ITS BROAD PORTFOLIO IN WIDE RANGE OF PATIENT POPULATIONS AT THE AMERICAN DIABETES ASSOCIATION 74TH SCIENTIFIC SESSIONS® 43 abstracts on approved products and an...
-
ASTRAZENECA UPDATES ON THE RAPID PROGRESS OF ITS ONCOLOGY PIPELINE AT ASCO 2014 The following amendment has been made to the 'ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ASCO' announcement released...